BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 8, 2019
View Archived Issues
A11 Mb-IRDye800CW is a promising new probe for real-time fluorescence imaging in prostate cancer
Read More
Alios BioPharma presents first-in-human data for AL-794
Read More
FEN1 and APEX2 as potential new targets in BRCA2-mutant tumors
Read More
FDA clears IND application for FT-516 cell therapy derived from an engineered pluripotent stem cell
Read More
First mouse kidneys grown from mouse stem cells in rats
Read More
Recida Therapeutics launches to develop lead program, RC-01
Read More
AAV9 vector encoding modified HEXB shows promise in vivo for Tay-Sachs disease
Read More
China's NMPA clears IND for bispecific antibody IBI-318
Read More
Targeting NRAS activator STK19 blocks melanocyte malignant transformation and melanoma growth
Read More
Interim data presented from first-in-human study of AT-GAA in patients with Pompe disease
Read More
Sanofi Genzyme presents long-term safety data for avalglucosidase alfa in Pompe disease
Read More
iVeena initiates phase I/IIa study of IVMED-80
Read More
Preliminary data presented from phase II study of MGTA-456 in inherited metabolic disorders
Read More
DSMB completes its third review of phase I/IIa study of VBI-1901 in recurrent GBM
Read More
Interim phase IIb data shows promising signs of clinical benefit for MDNA-55 in rGBM
Read More
New phase III study of empagliflozin assesses cardio-renal outcomes in chronic kidney disease
Read More
Moleculin's third drug candidate approved to enter clinical testing
Read More
Antidote Therapeutics to collaborate with NCI on development of ATI-1013
Read More
Ligand Pharmaceuticals enters OmniAb collaboration with Genagon Therapeutics
Read More
2-AG is a predictor of poor outcome in patients with aSAH
Read More
FDA clears IND for phase II study of Pulmazole in allergic bronchopulmonary aspergillosis
Read More
AbbVie patents lysophospholipid S1P5 receptor agonists
Read More
Phenex-FXR presents modulators of oxysterol receptors
Read More
Improved liver-targeted AAV gene therapy has long-lasting effects in Fabry disease model
Read More
Bayer and DKFZ jointly identify MAP4K1 inhibitors
Read More
Selection Biosciences divulges new 3-quinuclidone compounds
Read More
Chinese researchers disclose EGFR inhibitors
Read More
Sanofi to seek new partner for ophthalmology gene therapies SAR-422459 and SAR-421869
Read More